IMR Press / FBL / Volume 13 / Issue 1 / DOI: 10.2741/2682

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Heart failure and cachexia: insights offered from molecular biology
Show Less
1 Department of Cardiology, Centre for Cell Therapy and Regenerative Medicine, University Hospital Antwerp, Belgium
Front. Biosci. (Landmark Ed) 2008, 13(1), 325–335; https://doi.org/10.2741/2682
Published: 1 January 2008
Abstract

Chronic heart failure (CHF) is an enormous medical and communal burden. The syndrome is common, carries a grim prognosis and severely impacts quality of life. Those patients who develop cardiac cachexia combat both important disability and a poor outlook. Muscle wasting is a critical component of cachexia. The pathophysiological determinants are numerous and some of them are common to other chronic severe illnesses. There is increasing awareness, however, that heart failure related myopathy is a distinct entity, characterized by specific functional, structural and morphologic changes and the involvement of several neurohormonal pathways, catabolic processes, a pro-inflammatory environment and increased oxidative stress. Although clear-cut evidence based solutions for the problem are not readily available, the modulating effects of regular exercise in CHF patients suggest that physical training should at least be incorporated in the essentially multi-disciplinary approach.

Share
Back to top